Evidence map›Paper›PMID 33783609›Full record

ArticleCell and tissue research2021

LncRNA KCNQ1OT1 attenuates osteoarthritic chondrocyte dysfunction via the miR-218-5p/PIK3C2A axis.

Yijun Liu, Ding Zhao, Xue Wang, Ying Dong, Fupeng Ding

Abstract read
PubMed Publisher
In one paragraph

Article in Cell and tissue research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Ion channels as therapeutic targets in osteoarthritis.Trends in pharmacological sciences · 2025
    Review
  6. Observational
  7. Review
  8. Review
  9. Epigenetics as a Therapeutic Target in Osteoarthritis.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Article
  12. An Overview of Class II Phosphoinositide 3-Kinases.Current topics in microbiology and immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yijun LiuDepartment of Orthopaedics, The First Hospital of Jilin University, 3302 Jilin Road, Changchun, 130000, Jilin, China.
Ding ZhaoDepartment of Orthopaedics, The First Hospital of Jilin University, 3302 Jilin Road, Changchun, 130000, Jilin, China.
Xue WangDepartment of Anesthesiology, The First Hospital of Jilin University, Changchun, 130000, Jilin, China.
Ying DongThe Third Department of Radiotherapy, Jilin Provincial Tumor Hospital, Changchun, 130012, Jilin, China.
Fupeng DingDepartment of Orthopaedics, The First Hospital of Jilin University, 3302 Jilin Road, Changchun, 130000, Jilin, China. ding666fu@jlu.edu.cn.ORCID http://orcid.org/0000-0002-6942-9660
Jilin University · CNJilin Province Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of osteoarthritis is closely related to chondrocyte dysfunction caused by cellular inflammatory response and matrix degradation, which seriously affect the quality of life of patients. Therefore, this study aimed to investigate the role of potassium voltage-gated channel subfamily Q member 1 overlapping transcript 1 (KCNQ1OT1), a member of the lncRNA voltage-gated channel subfamily Q, in the development of osteoarthritis. In this study, RT-qPCR results showed that KCNQ1OT1 expression was downregulated in osteoarthritic chondrocytes compared with normal chondrocytes. In addition, upregulation of KCNQ1OT1 significantly enhanced the viability of osteoarthritic chondrocytes, inhibited cell apoptosis, and reduced the release of inflammatory cytokines and metal matrix enzymes. Next, bioinformatics analysis and luciferase reporter gene analysis predicted and validated the targeting relationship between KCNQ1OT1 and miR-218-5p. We found that the expression of miR-218-5p was significantly upregulated in osteoarthritic chondrocytes, and knockdown of miR-218-5p significantly enhanced the viability of osteoarthritic chondrocytes, inhibited apoptosis, and decreased the abundance of inflammatory cytokines and metal matrix enzymes. Furthermore, the targeting relationship between miR-218-5p and recombinant phosphoinositide-3-kinase class-2-alpha polypeptide (PIK3C2A) was identified, and overexpression of PIK3C2A enhanced cell viability, and reduced apoptosis and secretion of inflammatory factors. Finally, we found that miR-218-5p overexpression reversed the protective effect of overexpression of KCNQ1OT1 or PIK3C2A on osteoarthritic chondrocytes. In conclusion, our results demonstrated that KCNQ1OT1 upregulated PIK3C2A and activated the PI3K/AKT/mTOR pathway to reduce chondrocyte dysfunction by targeting miR-218-5p, providing new insights into the pathogenesis of osteoarthritis.

Indexed as

AgedChondrocytesHumansMicroRNAsMiddle AgedOsteoarthritisPhosphatidylinositol 3-KinasesPotassium Channels, Voltage-GatedSignal TransductionKCNQ1OT1 long non-coding RNA, humanMicroRNAsMIRN218 microRNA, humanPhosphatidylinositol 3-KinasesPIK3C2A protein, humanPotassium Channels, Voltage-GatedLncRNA KCNQ1OT1MiR-218-5pOsteoarthritisPIK3C2AThe PI3K/AKT/ mTOR pathway

Identifiers

PMID33783609
OpenAlexW3139938293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.